A drug which reduces the amount of acid released by the stomach. It is used to treat peptic ulcers and gastritis.
Oral/parenteral H2 histamine blocker used in the treatment of peptic ulcer, gastritis, and gastroesophageal reflux.
An antiulcer drug used in the long-term treatment of gastric ulcers. Ranitidine (Zantac) is also used in the short-term treatment of duodenal and gastric ulcers and to prevent ulcers caused by stress. Ranitidine is used to treat gastroesophageal reflux disease (GERD), in which stomach acid leaks back into the esophagus, causing painful heartburn and other stomach conditions from over-secretion of gastric acid.
An H2-receptor antagonist drug used in the treatment of duodenal ulcer by reducing the hyperacidity of the gastric juice. The drugs blocks the production of histamine produced by mast cells in the stomach lining. Histamine stimulates the acid-secreting cells in the stomach. Ranitidine, like other H2-blocking drugs, should be used in combination with an antibiotic drug to treat ulcers caused by helicobacter pylori infection in the stomach. The drug should be given for up to eight weeks with repeat courses if ulcers recur.
A histamine H2 antagonist and antiulcer agent, administered orally or intravenously for shortterm treatment of active duodenal ulcers and benign gastric ulcers.
Ranitidine, a member of the H2-receptor antagonist category, is a medication employed for the healing of ulcers. It is utilized to both prevent and treat peptic ulcers, as well as to address oesophagitis, which is inflammation of the oesophagus. Potential side effects encompass headaches, skin rashes, nausea, constipation, and lethargy.